HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Google Scholar Articles by Chong, C. F. PubMed Articles by Chong, C. F. Related Collections Lung - cancer Lung - other Mediastinum Trachea and bronchi

Letters to the Editor

Re: Prognostic value of FDG uptake in early stage non-small cell lung cancer

Thoracic Unit, Department of Surgery, Raja Isteri Pengiran Anak Saleha Hospital, Bandar Seri Begawan BA 1710, Brunei Darussalam

Received 9 June 2008; accepted 14 July 2008.

^_* Corresponding author. Tel.: +673 2 242424; fax: +673 2 333270. (Email: chong_chee_fui@hotmail.com).

Key Words: 2-[18F] Fluoro-2-deoxy-D-glucose (FDG) • Non-small cell lung cancer (NSCLC) • Standard uptake value (SUV) • Early TNM stage • Prognosis

The first 20% of the full text of this article appears below.

I read with interest the article by Hanin and colleagues regarding the prognostic value of 2-[18F] fluoro-2-deoxy-D-glucose (FDG) uptake in early stage non-small cell lung cancer (NSCLC), published recently in the May issue of the European Journal of Cardio-thoracic Surgery [1]. Standardised uptake value (SUV) of FDG has previously been shown to prognosticate disease recurrence and survival in patients with early stage NSCLC [2,3]. The current study also reported similar findings. However, there are several faults with the data presentation and analysis in this article.

First, unlike previous studies which all . . . [Full Text of this Article]